Clinical trial
Ziprasidone vs. Sertraline/Haloperidol in Psychotic Depression
NCT00340379 · Duke University, Other · Completed
Key facts
| NCT number | NCT00340379 |
|---|---|
| Title | Ziprasidone vs. Sertraline/Haloperidol in Psychotic Depression |
| Official title | A Comparison of Two Different Treatments for Major Depression With Psychotic Features: Ziprasidone vs. Combined Sertraline and Haloperidol |
| Lead sponsor | Duke University, Other |
| Collaborators | Pfizer Industry National Institute of Mental Health and Neuro Sciences, India |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Affective Disorders |
| Intervention type | Drug |
| Interventions | Ziprasidone, Sertraline, Haloperidol |
| Enrollment | 72 |
| Start date | Apr 1, 2003 |
| Primary completion | Aug 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Jun 21, 2006 |
| Last update posted | Aug 19, 2014 |
| Countries | Egypt, India, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: